Addex to Present at the Virtual German Equity Forum
Geneva, Switzerland, November 18, 2021 - Addex Therapeutics (SIX: ADXN, Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that CEO, Tim Dyer, and Head of Discovery – Biology, Dr Robert Lütjens, will be attending the virtual German Equity Forum to be held November 22 – 24, 2021. Mr Dyer’s presentation is scheduled for November 23, 2021 at 08:00 EST / 14:00 CET.
In his presentation, Mr Dyer will provide a corporate update and discuss recent developments at Addex. The video presentation will be available for viewing on-demand by registered participants.
Management will be available for virtual one-on-one meetings throughout the conference. For more information or to schedule a one-on-one meeting with management, please contact your conference representative or [email protected].
About Addex Therapeutics:
Addex Forward Looking Statements:
Face the Music: The New Age of Bluetooth
Smart City â€“ First Responder Solutions
Session Details TBA